Introduction
In recent years, evidence has accumulated supporting a role for innate and adaptive immune cells in maintaining lung health, and it has been reported that T cell populations play an important role in pathogen immune surveillance [1] . Lung airway CD3 + T cells express the memory CD45RO + antigen, but T RM comprise a mixture of subpopulations that have not been fully characterized. Studies in mouse models have revealed a pool of T cells in lung airways that is maintained by the continual recruitment of new cells from the lymph nodes and blood [2] . In humans, the Killer cell lectin-like receptor subfamily B, member 1, also known as KLRB1, NKR-P1A (CD161), which is a C-type lectin that is expressed on the cell surface of CD3 + T cells, including the CD4 + and CD8 + subpopulations [3, 4] , is expressed on memory T cell subsets with tissue-homing capacity. In blood, it has been reported that CD161 is expressed by 23% of the CD4 + T cells [5] . Tissue-resident CD161 + T cells have been reported in the liver, intestine and skin [8] [9] [10] [11] .
The ability of these cells to migrate could be mediated by the CD161 receptor, which binds to acidic oligosaccharides on the endothelial cell surface. In vitro migration assays have revealed that CD4 + CD161 + cells have a greater capacity to migrate than CD4 + CD161 -cells, and the direct participation of CD161 in migration has been demonstrated, as treatment with anti-CD161 antibodies inhibits the migration process [12] . The expression of CXC chemokine receptor type 6 (CXCR6) together with CD161 has been reported; furthermore, CXCR6 binds the CXC chemokine ligand (CXCL16), which is constitutively expressed in the liver and respiratory tract [4, 13] . It has been proposed that CD3 + CD161 + T cells can migrate from the peripheral blood to tissue; however, the frequency and function of these cells in the lung under steady-state conditions is unknown. In this study, we analyzed the expression of CD161 on CD3 + lymphocytes and the cytokine production profiles of BACs in healthy subjects. We investigated subsets of CD3 + CD161 + memory resident T cells with the capacity to simultaneously secrete IFN-γ and IL-17.
Material and Methods

Subjects
Twenty-two healthy subjects were recruited at the National Institute of Respiratory Diseases "Ismael Cosío Villegas". Each subject provided written informed consent prior bronchoalveolar lavage (BAL) and venipuncture procedures. The subjects were nonsmokers, seronegative for HIV-1, had normal chest X-ray, and no history of pulmonary or cardiac disease, chronic diseases or recent infections. In addition, the fluids of bronchoalveolar lavages of eight subjects matching the inclusion criteria from an institutional samples bank were included. Overall, the study group was of a median age of 26 (range 18-56) years, 41% female, and 59% male.
Ethics Statement
National Institute of Respiratory Diseases Institutional Review Board approved the protocol. Each subject provided written informed consent prior to any procedure. The personal information was coded and the study research records were stored as confidential information.
Bronchoalveolar lavage and blood sampling
BAL was performed at the Bronchoscopy Service according to the procedure described by Hirsch et al. [14] Briefly, after local anesthesia of the upper airways with 2% lidocaine solution and the additional instillation of 1% lidocaine in the lower airways, a flexible fiberoptic bronchoscope (P30, Olympus BF, New Hyde Park, NY) was wedged into two segments of the right middle lobe. A 300ml of sterile saline solution (150ml/segment) was instilled in 20ml aliquots and recovered. The average amount of recovered BAL fluid was 78%.
Prior to the bronchoscopy, 5ml peripheral blood samples were obtained from all volunteers by phlebotomy and were placed into 5ml heparin tubes (BD Vacutainer, BD Bioscience, San Jose, CA).
Bronchoalveolar cells and peripheral blood mononuclear cell isolation
After recovery, BAL fluid was centrifuged at 300 x g for 15 min at 4°C, and BACs were suspended in complete medium [RPMI 1640 medium (Lonza, Walkersville, MD, USA) with 2 mM L-glutamine (Sigma Chemical Co., St Louis, MO), 50 mg/ml gentamycin sulfate (Lonza) and 10% heat-inactivated pooled AB human serum (Gemini, Woodland, CA)] at 1 x 10 6 cells/ml.
The average cell viability was 98% based on trypan blue exclusion (Gibco Life Technologies, Grand Island, NY). The BAL fluids were aliquoted and kept at -70°C until used. PBMCs were obtained by centrifugation using lymphocyte separation solution (Lonza), and their viability was 99% based on trypan blue exclusion.
Cell surface phenotype by flow cytometry analysis
PBMCs or BACs from healthy individuals were stained with the monoclonal antibodies to the following human antigens: CD161-FITC, CD45RO-PE (BD Biosciences, San Jose, CA), CD4-APE-Cy7, CD8-PE-Cy7, CXCR6-APC (Biolegend San Diego, CA) or CD3-PE-TexRed (Invitrogen, Carlsbad, CA) and then by their respective IgG isotypes. Briefly, 2.5 x 10 5 PBMCs or BACs were incubated with antibody for 15 min at room temperature in the dark. Then, BACs and blood samples were washed twice with phosphate-buffered saline (PBS) containing 2% fetal bovine serum (wash solution). The supernatants were discarded and resuspended in PBS and 100,000 cells were acquired using a FACSCanto II flow cytometer (BD Biosciences). Data analysis was performed using FlowJo research software version 8.9 (Tree Star, Inc. Ashland, OR).
Analysis of IFN-γ, IL-4, IL-17 and TNF-α production by flow cytometry
To evaluate intracellular cytokine production, 1 x 10 6 PBMCs or BACs were stimulated with Phorbol-12-Myristate-13-Acetate (PMA, 25 ng/ml, Sigma Chemical, St. Louis, MO) plus ionomycin (1μM, Sigma Chemical) in the presence of brefeldin A (5 μg/ml, Sigma Chemical) for 4 h at 37°C and in 5% CO 2 
Quantification of CXCL16 in BAL fluid
CXCL16 was determined by ELISA using commercial kits from PeproTech and read at 405nm/ 630nm in a Labsystems Multiskan MCC/340 (Labsystems, Finland). Briefly, 10ml of the BAL fluid were lyophilized and reconstituted in 1ml of double-distilled water for a 10-fold concentration. The CXCL16 concentration was reported as pg/ml of BAL fluid.
Statistical analysis
Comparisons between two groups were evaluated using the nonparametric Mann-Whitney Rank Sum Test. For multiple comparisons, we used the Kruskal-Wallis test followed by Dunn's Multiple Comparison post-test. Statistical analysis was performed using GraphPad prism, version 5.0 statistical software (GraphPad, San Diego, CA). Statistical significance was considered when p 0.05.
Results
A subset of CD3 + CD161 + T lymphocytes resides in the bronchoalveolar space
Previous studies have identified a subpopulation of T lymphocytes, CD3 + CD161 + , with the capacity to migrate from peripheral blood to tissue under steady-state conditions. Anti-CD3 and anti-CD161 monoclonal antibodies were used to evaluate the percentage of resident CD3 + CD161 + T lymphocytes in the alveolar compartment and in peripheral blood of healthy volunteers ( Fig 1A) . 8.6% (range: 2.5-21) of the BACs were CD3 + T lymphocytes, and within the CD3 + population, 4.6% (2.12-11.3) expressed CD161 on the surface (Fig 1B) . This CD3 + CD161 + subset of T cells was present at a significantly lower proportion in the alveolar compartment than in the blood (BACs 4.6% vs PBMCs 8.4%; P<0.05) (Fig 1B) . CD161 expression on CD4 + and CD8 + T lymphocyte subsets of alveolar cells was also examined, and found that 2.17% of CD4 + T lymphocytes and 1.52% of CD8 + T cells expressed the (Fig 2B) .
The CD161 + alveolar T lymphocytes produce less IFN-γ than CD161-lymphocytes
To identify the functional phenotype of CD161 + and CD161 − T cells, the Type 1 (IFN-γ), Type 2 (IL-4), Type 17 (IL-17) and TNF-α production, CD161 + and CD161 − alveolar lymphocytes upon PMA plus ionomycin stimulation was evaluated (Fig 3A) . The percentage of IFN-γ-producing cells was significantly lower in CD3 + CD161 + T alveolar lymphocytes than in CD3 + CD161 − T alveolar lymphocytes (Fig 3B) . (Fig 4B) . + cells producing IFN-γ n = 7), TNF-α, IL-4 and IL-17; n = 4. P values were generated using the Kruskal-Wallis test followed by Dunn's Multiple Comparison between BACs and PBMCs. doi:10.1371/journal.pone.0123591.g002
CD3+CD161+ T Cells Are Resident Memory T Cells (TRM) in the Lung
Discussion
The importance of T RM on immune response has been well documented in different species and tissues. These cells are critical for host defense and homeostasis in the lung. Homeostasis involves a continuous process of recruiting T RMs from the periphery under normal non-inflamed conditions [15] [16] [17] [18] .
In this study, we evaluated the CD3 + CD161 + T RM cells in BAL fluid from healthy human subjects. It has been reported that under non-inflammatory conditions, resident CD3 + T cells represent 5-10% of BACs, and our data are consistent with these results [19, 20] . found at increased proportions in the liver, colon, epithelium, and duodenum [8] [9] [10] ; however, these studies were performed on patients with cancer, and those who had undergone liver transplantation or had gastrointestinal symptoms [24] . CD161 expression has been reported on 1.2% of CD4 + and 1.5% of CD8 + T cells from the BAL fluid of patients with hypersensitivity pneumonitis [25] . Although the former study did not include healthy volunteers, our results are similar.
Previously, it has been demonstrated that human lungs contain a large T RM population that can respond rapidly to challenges in the environment [18] . CD161 expression has been proposed as a marker of memory cells that have the capacity to migrate to the lungs [5, 12, 26, 27] . Our results are consistent with this idea; we found that 74% of alveolar CD3 [4, 12, 13, 28] . Our results showed that peripheral CD3+CD161+ T cells express CXCR6 and the levels of CXCL16 detected in the BAL fluids suggest the migration of the CD3+CD161+ cells to the lungs. Recently, the expression of CD161 has been linked to the Th17 and Tc17 phenotypes in blood and tissues. [4, 29, 30] . In this study we observed that the majority of IL-17/IFN-γ-secreting cells expressed the CD161 + receptor.
One of the functions of Th17/Th1 cells includes coordinating local tissue inflammation [31] . These cells are resistant to the actions of T reg cells, suggesting the importance of these cells in autoimmune disorders. In addition, Th17/Th1 cells appear to be different from pure Supporting Information 
